[1] Daver N,Schlenk RF,Russell NH,et al. Targeting FLT3 mutations in AML:review of current knowledge and evidence[J]. Leukemia,2019,33(2):299~312. [2] Li D,Luo Y,Chen X,et al. NF-κB and poly (ADP-ribose) polymerase 1 form a positive feedback loop that regulates DNA repair in acute myeloid leukemia cells[J].Mol Cancer Res,2019,17(3):761~772. [3] Tan SF,Dunton W,Liu X,et al. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation[J].Lipid Res,2019,60(6):1078~1086. [4] Zhang Jing,Gu Yan,Chen Baoan. Mechanisms of drug resistance in acute myeloid leukemia[J]. OncoTargets and therapy,2019,12:1937~1945. [5] Li Y,Guo Y,Feng Z,et al. Involvement of the PI3K/Akt/Nrf2 Signaling pathway in resveratrol-mediated reversal of drug resistance in HL-60/ADR cells[J]. Nutr Cancer,2019,71(6):1007~1018. [6] Li X,He S,Ma B. Autophagy and autophagy-related proteins in cancer[J]. Mol Cancer,2020,19(1),12. [7] Niu Y,Yang X,Chen Y,et al. EVI1 induces autophagy to promote drug resistance via regulation of ATG7 expression in leukemia cells[J]. Carcinogenesis,2020,41(7):961~971. [8] Piya S,Andreeff M,Borthakur G. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia[J]. Autophagy,2017,13(1):214~215. [9] Li H,Li J,Cheng J,et al. AMLderived mesenchymal stem cells upregulate CTGF expression through the BMP pathway and induce K562ADM fusiform transformation and chemoresistance[J]. Oncol Rep,2019,42(3):1035~1046. [10] Francesca Chiarini,Francesca Paganelli,Alberto M. Martelli,et al. The role played by Wnt/β-catenin signaling pathway in acute lymphoblastic leukemia[J]. Int Mol Sci,2020,21(3):1098. [11] Liu B,Ma H,Liu Q,et al. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia[J].Exp Clin Cancer Res,2019,38(1):200. [12] Chen L,Hu N,Wang C,et al. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells[J]. Arch Biochem Biophys,2020,680:108244. [13] Takam Kamga P,Bassi G,Cassaro A,et al. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia[J]. Oncotarget,2016,7(16):21713~21727. [14] Papa S,Choy PM,Bubici C. The ERK and JNK pathways in the regulation of metabolic reprogramming[J]. Oncogene,2019,38 (13):2223~2240. [15] Li M,Meng F,Lu Q. Expression profile screening and bioinformatics analysis of circRNA,LncRNA,and mRNA in acute myeloid leukemia drug-resistant cells[J].Turk Haematol,2020,37(2):104~110. [16] Han L,Zhang Q,Dail M,et al. Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models[J]. Haematologica,2020,105(3):697~707.
2021, Vol. 27 
冀公网安备13080202000786号